Targeting PD-L1 for PCNS-DLBCL: from molecular effects to clinical translation
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research on primary central nervous system lymphoma is being translated from molecular effects to clinical applications. This includes targeting pd-l1 for primary central nervous system diffuse large b-cell lymphoma. Progress is being made from a research setting to potential treatment.